- University / research
- Country: United States
Modeling CNS inflammatory demyelination using myelin-directed CAR T cells
Multiple sclerosis therapies remain confined to immunomodulatory agents that reduce inflammatory activity; none restores lost myelin, and disability can continue to accumulate independently of relapses. Development of remyelinating therapies has been hindered by models that incompletely reproduce…